Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 806 entries
Sorted by: Best Match Show Resources per page
Corrigendum.

Journal of psychopharmacology (Oxford, England)

[No authors listed]
PMID: 25744619
J Psychopharmacol. 2015 Apr;29(4):456. doi: 10.1177/0269881115577574. Epub 2015 Mar 05.

Corrigendum for 'GENETIC DIFFERENCES IN CYTOCHROME P450 ENZYMES AND ANTIDEPRESSANT TREATMENT RESPONSE' by: Karen Hodgson, Katherine Tansey, Mojca Zvezdana Dernovšek, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Rebecca Smith, Ian W Craig,...

Cite
Corrigendum. J Psychopharmacol. 2015;29(4):456doi: 10.1177/0269881115577574.
(2015). Corrigendum. Journal of psychopharmacology (Oxford, England), 29(4), 456. https://doi.org/10.1177/0269881115577574
"Corrigendum." Journal of psychopharmacology (Oxford, England) vol. 29,4 (2015): 456. doi: https://doi.org/10.1177/0269881115577574
Corrigendum. J Psychopharmacol. 2015 Apr;29(4):456. doi: 10.1177/0269881115577574. Epub 2015 Mar 05. PMID: 25744619.
Copy Download .nbib Format: NLM
Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment.

Journal of psychopharmacology (Oxford, England)

Prikryl R, Kucerova H.
PMID: 15888504
J Psychopharmacol. 2005 May;19(3):313. doi: 10.1177/0269881105051545.

No abstract available.

Cite
Prikryl R, Kucerova H. Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment. J Psychopharmacol. 2005;19(3):313doi: 10.1177/0269881105051545.
Prikryl, R., & Kucerova, H. (2005). Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment. Journal of psychopharmacology (Oxford, England), 19(3), 313. https://doi.org/10.1177/0269881105051545
Prikryl, Radovan, and Kucerova, Hana. "Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment." Journal of psychopharmacology (Oxford, England) vol. 19,3 (2005): 313. doi: https://doi.org/10.1177/0269881105051545
Prikryl R, Kucerova H. Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment. J Psychopharmacol. 2005 May;19(3):313. doi: 10.1177/0269881105051545. PMID: 15888504.
Copy Download .nbib Format: NLM
Concerns about conflict of interest.

Journal of psychopharmacology (Oxford, England)

Healy D.
PMID: 15888518
J Psychopharmacol. 2005 May;19(3):314-5; author reply 316. doi: 10.1177/0269881105054665.

No abstract available.

Cite
Healy D. Concerns about conflict of interest. J Psychopharmacol. 2005;19(3):314-5; author reply 316doi: 10.1177/0269881105054665.
Healy, D. (2005). Concerns about conflict of interest. Journal of psychopharmacology (Oxford, England), 19(3), 314-5; author reply 316. https://doi.org/10.1177/0269881105054665
Healy, David. "Concerns about conflict of interest." Journal of psychopharmacology (Oxford, England) vol. 19,3 (2005): 314-5; author reply 316. doi: https://doi.org/10.1177/0269881105054665
Healy D. Concerns about conflict of interest. J Psychopharmacol. 2005 May;19(3):314-5; author reply 316. doi: 10.1177/0269881105054665. PMID: 15888518.
Copy Download .nbib Format: NLM
Retracted. The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine.

Journal of psychopharmacology (Oxford, England)

[No authors listed]
PMID: 18719042
J Psychopharmacol. 2013 Dec;27(12):1186. doi: 10.1177/0269881108094888. Epub 2008 Aug 21.

No abstract available.

Cite
Retracted. The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine. J Psychopharmacol. 2008;27(12):1186doi: 10.1177/0269881108094888.
(2013). Retracted. The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine. Journal of psychopharmacology (Oxford, England), 27(12), 1186. https://doi.org/10.1177/0269881108094888
"Retracted. The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine." Journal of psychopharmacology (Oxford, England) vol. 27,12 (2013): 1186. doi: https://doi.org/10.1177/0269881108094888
Retracted. The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine. J Psychopharmacol. 2013 Dec;27(12):1186. doi: 10.1177/0269881108094888. Epub 2008 Aug 21. PMID: 18719042.
Copy Download .nbib Format: NLM
Psychopharmacological imaging.

Journal of psychopharmacology (Oxford, England)

Nutt DJ.
PMID: 22298392
J Psychopharmacol. 1995 Jan;9(4):293. doi: 10.1177/026988119500900401.

No abstract available.

Cite
Nutt DJ. Psychopharmacological imaging. J Psychopharmacol. 1995;9(4):293doi: 10.1177/026988119500900401.
Nutt, D. J. (1995). Psychopharmacological imaging. Journal of psychopharmacology (Oxford, England), 9(4), 293. https://doi.org/10.1177/026988119500900401
Nutt, D J. "Psychopharmacological imaging." Journal of psychopharmacology (Oxford, England) vol. 9,4 (1995): 293. doi: https://doi.org/10.1177/026988119500900401
Nutt DJ. Psychopharmacological imaging. J Psychopharmacol. 1995 Jan;9(4):293. doi: 10.1177/026988119500900401. PMID: 22298392.
Copy Download .nbib Format: NLM
Impairment of performance associated with long-term use of benzodiazepines.

Journal of psychopharmacology (Oxford, England)

Gorenstein C, Bernik MA, Pompéia S, Marcourakis T.
PMID: 22298395
J Psychopharmacol. 1995 Jan;9(4):313-8. doi: 10.1177/026988119500900404.

The long-term effects of benzodiazepines (BDZ) on psychomotor and cognitive functions were assessed in 28 out patients, users of low therapeutic doses of diazepam (13.6 ± 4.9 mg/day, range: 5-20 mg/day) for 5-20 years (10.1 ± 5.0 years). These...

Cite
Gorenstein C, Bernik MA, Pompéia S, et al. Impairment of performance associated with long-term use of benzodiazepines. J Psychopharmacol. 1995;9(4):313-8doi: 10.1177/026988119500900404.
Gorenstein, C., Bernik, M. A., Pompéia, S., & Marcourakis, T. (1995). Impairment of performance associated with long-term use of benzodiazepines. Journal of psychopharmacology (Oxford, England), 9(4), 313-8. https://doi.org/10.1177/026988119500900404
Gorenstein, C, et al. "Impairment of performance associated with long-term use of benzodiazepines." Journal of psychopharmacology (Oxford, England) vol. 9,4 (1995): 313-8. doi: https://doi.org/10.1177/026988119500900404
Gorenstein C, Bernik MA, Pompéia S, Marcourakis T. Impairment of performance associated with long-term use of benzodiazepines. J Psychopharmacol. 1995 Jan;9(4):313-8. doi: 10.1177/026988119500900404. PMID: 22298395.
Copy Download .nbib Format: NLM
A comparison of age-related deficits in memory and frontal lobe function following oral lorazepam administration.

Journal of psychopharmacology (Oxford, England)

Kirkby KC, Montgomery IM, Badcock R, Daniels BA.
PMID: 22298396
J Psychopharmacol. 1995 Jan;9(4):319-25. doi: 10.1177/026988119500900405.

Differential responses on cognitive function of young (18-45 years, n = 17) and elderly (60-75 years, n = 9) subjects were compared before and after a challenge with lorazepam (2 mg oral) or placebo. Tests of memory and frontal...

Cite
Kirkby KC, Montgomery IM, Badcock R, et al. A comparison of age-related deficits in memory and frontal lobe function following oral lorazepam administration. J Psychopharmacol. 1995;9(4):319-25doi: 10.1177/026988119500900405.
Kirkby, K. C., Montgomery, I. M., Badcock, R., & Daniels, B. A. (1995). A comparison of age-related deficits in memory and frontal lobe function following oral lorazepam administration. Journal of psychopharmacology (Oxford, England), 9(4), 319-25. https://doi.org/10.1177/026988119500900405
Kirkby, K C, et al. "A comparison of age-related deficits in memory and frontal lobe function following oral lorazepam administration." Journal of psychopharmacology (Oxford, England) vol. 9,4 (1995): 319-25. doi: https://doi.org/10.1177/026988119500900405
Kirkby KC, Montgomery IM, Badcock R, Daniels BA. A comparison of age-related deficits in memory and frontal lobe function following oral lorazepam administration. J Psychopharmacol. 1995 Jan;9(4):319-25. doi: 10.1177/026988119500900405. PMID: 22298396.
Copy Download .nbib Format: NLM
Psychoactive drugs of use and abuse: wobble, rave, inhale or crave? Symposium organised by the Psychobiology Section, at the British Psychological Society Annual Conference, University of Warwick, UK; 2nd April 1995: Convenors: Dr Andy Parrott, Department of Psychology, University of East London, London E15 4LZ Dr Martin Yeomans, Department of Experimental Psychology, University of Sussex, Sussex BN1 9DG.

Journal of psychopharmacology (Oxford, England)

Parrott A.
PMID: 22298407
J Psychopharmacol. 1995 Jan;9(4):390-1. doi: 10.1177/026988119500900416.

No abstract available.

Cite
Parrott A. Psychoactive drugs of use and abuse: wobble, rave, inhale or crave? Symposium organised by the Psychobiology Section, at the British Psychological Society Annual Conference, University of Warwick, UK; 2nd April 1995: Convenors: Dr Andy Parrott, Department of Psychology, University of East London, London E15 4LZ Dr Martin Yeomans, Department of Experimental Psychology, University of Sussex, Sussex BN1 9DG. J Psychopharmacol. 1995;9(4):390-1doi: 10.1177/026988119500900416.
Parrott, A. (1995). Psychoactive drugs of use and abuse: wobble, rave, inhale or crave? Symposium organised by the Psychobiology Section, at the British Psychological Society Annual Conference, University of Warwick, UK; 2nd April 1995: Convenors: Dr Andy Parrott, Department of Psychology, University of East London, London E15 4LZ Dr Martin Yeomans, Department of Experimental Psychology, University of Sussex, Sussex BN1 9DG. Journal of psychopharmacology (Oxford, England), 9(4), 390-1. https://doi.org/10.1177/026988119500900416
Parrott, A. "Psychoactive drugs of use and abuse: wobble, rave, inhale or crave? Symposium organised by the Psychobiology Section, at the British Psychological Society Annual Conference, University of Warwick, UK; 2nd April 1995: Convenors: Dr Andy Parrott, Department of Psychology, University of East London, London E15 4LZ Dr Martin Yeomans, Department of Experimental Psychology, University of Sussex, Sussex BN1 9DG." Journal of psychopharmacology (Oxford, England) vol. 9,4 (1995): 390-1. doi: https://doi.org/10.1177/026988119500900416
Parrott A. Psychoactive drugs of use and abuse: wobble, rave, inhale or crave? Symposium organised by the Psychobiology Section, at the British Psychological Society Annual Conference, University of Warwick, UK; 2nd April 1995: Convenors: Dr Andy Parrott, Department of Psychology, University of East London, London E15 4LZ Dr Martin Yeomans, Department of Experimental Psychology, University of Sussex, Sussex BN1 9DG. J Psychopharmacol. 1995 Jan;9(4):390-1. doi: 10.1177/026988119500900416. PMID: 22298407.
Copy Download .nbib Format: NLM
Alcohol consumption and lifestyle in medical students.

Journal of psychopharmacology (Oxford, England)

File SE, Mabbutt PS, Shaffer J.
PMID: 22298476
J Psychopharmacol. 1994 Jan;8(1):22-6. doi: 10.1177/026988119400800104.

1st, 2nd, 3rd and 5th year medical students completed a questionnaire with 35 questions relating to diet, general health, exercise, smoking and drinking. Based on reported 'typical weekly intake' one-third of male non-Asian students in years 1-3, and 59%...

Cite
File SE, Mabbutt PS, Shaffer J. Alcohol consumption and lifestyle in medical students. J Psychopharmacol. 1994;8(1):22-6doi: 10.1177/026988119400800104.
File, S. E., Mabbutt, P. S., & Shaffer, J. (1994). Alcohol consumption and lifestyle in medical students. Journal of psychopharmacology (Oxford, England), 8(1), 22-6. https://doi.org/10.1177/026988119400800104
File, S E, et al. "Alcohol consumption and lifestyle in medical students." Journal of psychopharmacology (Oxford, England) vol. 8,1 (1994): 22-6. doi: https://doi.org/10.1177/026988119400800104
File SE, Mabbutt PS, Shaffer J. Alcohol consumption and lifestyle in medical students. J Psychopharmacol. 1994 Jan;8(1):22-6. doi: 10.1177/026988119400800104. PMID: 22298476.
Copy Download .nbib Format: NLM
Psychiatric complications of 'Ecstasy' use.

Journal of psychopharmacology (Oxford, England)

Series H, Boeles S, Dorkins E, Peveler R.
PMID: 22298482
J Psychopharmacol. 1994 Jan;8(1):60-1. doi: 10.1177/026988119400800110.

Two case reports are presented of significant psychiatric disorders associated with ingestion of 'Ecstasy' (3,4-methylenedioxymethamphetamine), a recreational drug whose use appears to be increasing. In one case, the patient developed a brief paranoid psychosis which recurred and persisted for...

Cite
Series H, Boeles S, Dorkins E, et al. Psychiatric complications of 'Ecstasy' use. J Psychopharmacol. 1994;8(1):60-1doi: 10.1177/026988119400800110.
Series, H., Boeles, S., Dorkins, E., & Peveler, R. (1994). Psychiatric complications of 'Ecstasy' use. Journal of psychopharmacology (Oxford, England), 8(1), 60-1. https://doi.org/10.1177/026988119400800110
Series, H, et al. "Psychiatric complications of 'Ecstasy' use." Journal of psychopharmacology (Oxford, England) vol. 8,1 (1994): 60-1. doi: https://doi.org/10.1177/026988119400800110
Series H, Boeles S, Dorkins E, Peveler R. Psychiatric complications of 'Ecstasy' use. J Psychopharmacol. 1994 Jan;8(1):60-1. doi: 10.1177/026988119400800110. PMID: 22298482.
Copy Download .nbib Format: NLM
New insights into classical issues in schizophrenia.

Journal of psychopharmacology (Oxford, England)

Waddington JL, Lieberman JA.
PMID: 22298485
J Psychopharmacol. 1994 Jan;8(1):65-6. doi: 10.1177/026988119400800113.

No abstract available.

Cite
Waddington JL, Lieberman JA. New insights into classical issues in schizophrenia. J Psychopharmacol. 1994;8(1):65-6doi: 10.1177/026988119400800113.
Waddington, J. L., & Lieberman, J. A. (1994). New insights into classical issues in schizophrenia. Journal of psychopharmacology (Oxford, England), 8(1), 65-6. https://doi.org/10.1177/026988119400800113
Waddington, J L, and Lieberman, J A. "New insights into classical issues in schizophrenia." Journal of psychopharmacology (Oxford, England) vol. 8,1 (1994): 65-6. doi: https://doi.org/10.1177/026988119400800113
Waddington JL, Lieberman JA. New insights into classical issues in schizophrenia. J Psychopharmacol. 1994 Jan;8(1):65-6. doi: 10.1177/026988119400800113. PMID: 22298485.
Copy Download .nbib Format: NLM
Keep taking the tablets? Inadequate controls for concurrent psychotropic medication in studies of psychological treatments for panic disorder.

Journal of psychopharmacology (Oxford, England)

Power KG, Sharp DM.
PMID: 22298698
J Psychopharmacol. 1995 Jan;9(1):71-2. doi: 10.1177/026988119500900113.

No abstract available.

Cite
Power KG, Sharp DM. Keep taking the tablets? Inadequate controls for concurrent psychotropic medication in studies of psychological treatments for panic disorder. J Psychopharmacol. 1995;9(1):71-2doi: 10.1177/026988119500900113.
Power, K. G., & Sharp, D. M. (1995). Keep taking the tablets? Inadequate controls for concurrent psychotropic medication in studies of psychological treatments for panic disorder. Journal of psychopharmacology (Oxford, England), 9(1), 71-2. https://doi.org/10.1177/026988119500900113
Power, K G, and Sharp, D M. "Keep taking the tablets? Inadequate controls for concurrent psychotropic medication in studies of psychological treatments for panic disorder." Journal of psychopharmacology (Oxford, England) vol. 9,1 (1995): 71-2. doi: https://doi.org/10.1177/026988119500900113
Power KG, Sharp DM. Keep taking the tablets? Inadequate controls for concurrent psychotropic medication in studies of psychological treatments for panic disorder. J Psychopharmacol. 1995 Jan;9(1):71-2. doi: 10.1177/026988119500900113. PMID: 22298698.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 806 entries